127 related articles for article (PubMed ID: 10960190)
1. New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones.
Waisser K; Gregor J; Kubicová L; Klimesová V; Kunes J; Machácek M; Kaustová J
Eur J Med Chem; 2000; 35(7-8):733-41. PubMed ID: 10960190
[TBL] [Abstract][Full Text] [Related]
2. Highly active potential antituberculotics: 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dihiones substituted in ring-B by halogen.
Waisser K; Matyk J; Kunes J; Dolezal R; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2008 Dec; 341(12):800-3. PubMed ID: 19006090
[TBL] [Abstract][Full Text] [Related]
3. Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-diones.
Waisser K; Gregor J; Dostál H; Kunes J; Kubicová L; Klimesová V; Kaustová J
Farmaco; 2001 Oct; 56(10):803-7. PubMed ID: 11718275
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Palát K; Kaustová J; Danse HM; Möllmann U
Pharmazie; 2003 Feb; 58(2):83-94. PubMed ID: 12641321
[TBL] [Abstract][Full Text] [Related]
5. Relationships between the chemical structure of antimycobacterial substances and their activity against atypical strains. Part 14: 3-Aryl-6,8-dihalogeno-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Hladuvková J; Gregor J; Rada T; Kubicová L; Klimesová V; Kaustová J
Arch Pharm (Weinheim); 1998 Jan; 331(1):3-6. PubMed ID: 9507695
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
7. A note to the biological activity of benzoxazine derivatives containing the thioxo group.
Waisser K; Petrlíková E; Perina M; Klimesová V; Kunes J; Palát K; Kaustová J; Dahse HM; Möllmann U
Eur J Med Chem; 2010 Jul; 45(7):2719-25. PubMed ID: 20226572
[TBL] [Abstract][Full Text] [Related]
8. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
9. Similarity approach to QSAR. Application to antimycobacterial benzoxazines.
Gallegos A; Carbó-Dorca R; Ponec R; Waisser K
Int J Pharm; 2004 Jan; 269(1):51-60. PubMed ID: 14698576
[TBL] [Abstract][Full Text] [Related]
10. 3-Benzyl-2H-1,3-benzoxazine-2,4(3H)-diones, a new group of antimycobacterial compounds against potentially pathogenic strains.
Waisser K; Perina M; Kunes J; Klimesová V; Kaustová J
Farmaco; 2003 Nov; 58(11):1137-49. PubMed ID: 14572865
[TBL] [Abstract][Full Text] [Related]
11. [New groups of potential antitubercular agents: 3-(4-ethoxythiocarbonylphenyl)-2-H-benzoxazin-2,4(3H)-diones and 3-(4-ethoxythiocarbonylphenyl)-4-thioxy-2H-benzoxazin-2(3H)-ones].
Waisser K; Holý P; Bures O; Kunes J; Kaustová J
Ceska Slov Farm; 2003 Jan; 52(1):42-7. PubMed ID: 12685334
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal activity of 3-phenyl-2H-benzoxazine-2,4(3H)-diones.
Waisser K; Kubicová L; Buchta V; Kubanová P; Bajerová K; Jirásková L; Bednarík O; Bures O; Holý P
Folia Microbiol (Praha); 2002; 47(5):488-92. PubMed ID: 12503392
[TBL] [Abstract][Full Text] [Related]
13. The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Palát K; Kaustová J
Arch Pharm (Weinheim); 2007 May; 340(5):264-7. PubMed ID: 17516578
[TBL] [Abstract][Full Text] [Related]
14. High active potential antimycobacterial agents against Mycobacterium avium.
Karel W; Jiří K; Jiřina S
Ceska Slov Farm; 2012 Jun; 61(3):127-9. PubMed ID: 22913828
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides.
Waisser K; Drazková K; Kunes J; Klimesová V; Kaustová J
Farmaco; 2004 Aug; 59(8):615-25. PubMed ID: 15262531
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
18. Benzoxazines. II. Synthesis, conformational analysis, and structure--activity relationships of 3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide derivatives as potent and long-acting serotonin-3 (5-HT3) receptor antagonists.
Kuroita T; Marubayashi N; Sano M; Kanzaki K; Inaba K; Kawakita T
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2051-60. PubMed ID: 8945770
[TBL] [Abstract][Full Text] [Related]
19. Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria.
Shimizu S; Suzuki M; Tomoda A; Arai S; Taguchi H; Hanawa T; Kamiya S
Tohoku J Exp Med; 2004 May; 203(1):47-52. PubMed ID: 15185971
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activity of salicylanilide benzenesulfonates.
Krátký M; Vinšová J; Rodriguez NG; Stolaříková J
Molecules; 2012 Jan; 17(1):492-503. PubMed ID: 22222908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
